Dorian LPG
LPG
YETI Holdings
YETI
Workday
WDAY
Collegium Pharmaceutical
COLL
LIFE HEALTHCARE GROUP HOLDINGS UNSPON ADR EA REPR 4 ORD ZAR0.00
LTGHY
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -226.60%-1.8M | 179.20%1.07M | 125.45%1.17M | -109.38%-368K | -206.33%-3.68M | -88.11%1.42M | -165.26%-1.36M | -155.31%-4.6M | 3.98%3.92M | 255.58%3.46M |
Net income from continuing operations | -6.48%-49.51M | 14.54%-23.34M | -55.60%-11.44M | -3.46%-5.9M | -44.07%-8.84M | 71.60%-46.5M | -82.23%-27.31M | -2.04%-7.35M | 95.82%-5.7M | -18.49%-6.13M |
Operating gains losses | 214.22%685K | 84.21%245K | 529.69%403K | -90.00%4K | 273.68%33K | -61.62%218K | 318.03%133K | -89.63%64K | 600.00%40K | -195.00%-19K |
Depreciation and amortization | 17.03%19.44M | 72.08%7.11M | 5.32%4.97M | -5.47%3.62M | -4.83%3.74M | -3.06%16.61M | 4.08%4.13M | 21.83%4.72M | -20.05%3.82M | -12.74%3.93M |
Deferred tax | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Change In working capital | 54.40%19.68M | 85.91%10.23M | 386.81%6.46M | -67.94%1.51M | -69.00%1.49M | -50.64%12.75M | -55.66%5.5M | -122.95%-2.25M | -19.39%4.7M | 314.78%4.79M |
-Change in receivables | 378.33%835K | 449.76%2.86M | 12.95%-1.12M | -1,804.17%-2.45M | -6.79%1.55M | 90.34%-300K | -143.49%-818K | 31.42%-1.29M | 111.80%144K | 188.23%1.66M |
-Change in inventory | 78.30%24.56M | -30.25%7.73M | 1,689.32%12.56M | 1,388.67%5.39M | -169.02%-1.12M | -58.12%13.77M | -9.67%11.08M | -92.98%702K | -94.72%362K | -56.74%1.63M |
-Change in prepaid assets | -87.76%477K | -103.22%-142K | 90.97%-408K | -395.35%-1.14M | -40.07%2.17M | -64.00%3.9M | 3,944.04%4.41M | -239.62%-4.52M | 117.14%387K | -62.82%3.62M |
-Change in payables and accrued expense | 45.58%-3.1M | 100.84%80K | -302.19%-4.16M | -82.23%690K | 113.88%287K | 15.16%-5.69M | -920.60%-9.56M | 386.21%2.06M | 22.88%3.88M | 74.83%-2.07M |
-Change in other working capital | -389.88%-3.09M | -177.75%-304K | -152.07%-416K | -1,234.25%-974K | -2,698.00%-1.4M | 113.20%1.07M | 142.59%391K | 196.38%799K | 89.62%-73K | 99.11%-50K |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -226.60%-1.8M | 179.20%1.07M | 125.45%1.17M | -109.38%-368K | -206.33%-3.68M | -88.11%1.42M | -165.26%-1.36M | -155.31%-4.6M | 3.98%3.92M | 255.58%3.46M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 150.21%5.73M | -340.44%-991K | -91.72%535K | 103.21%1.19M | -74.13%5M | 1.45%-11.41M | 99.32%-225K | -10.14%6.46M | -892.26%-36.95M | 103.27%19.31M |
Net PPE purchase and sale | 70.47%-1.98M | 86.06%-98K | -0.43%-464K | 48.42%-1.06M | 89.79%-355K | 48.06%-6.7M | 44.25%-703K | 83.58%-462K | 52.94%-2.06M | 21.91%-3.48M |
Net business purchase and sale | --0 | --0 | --0 | ---- | ---- | 57.81%-3.05M | --0 | --147K | ---- | ---- |
Net investment purchase and sale | 493.03%7.55M | -303.57%-912K | -86.19%934K | 106.94%2.21M | -76.58%5.32M | -124.20%-1.92M | 101.41%448K | -32.36%6.76M | -452.63%-31.86M | 9.48%22.73M |
Net other investing changes | -43.40%150K | -36.67%19K | 622.22%65K | -77.91%36K | -52.38%30K | -56.70%265K | --30K | --9K | --163K | --63K |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | 150.21%5.73M | -340.44%-991K | -91.72%535K | 103.21%1.19M | -74.13%5M | 1.45%-11.41M | 99.32%-225K | -10.14%6.46M | -892.26%-36.95M | 103.27%19.31M |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | -1,884.98%-6.21M | 36.84%-48K | -6,272.41%-1.85M | -3,415.57%-4.29M | 67.44%-28K | 81.51%-313K | 52.20%-76K | 29.27%-29K | -6.09%-122K | 93.76%-86K |
Net issuance payments of debt | --0 | --0 | --0 | --0 | --0 | 53.70%-50K | --0 | 29.17%-17K | 22.73%-17K | 30.43%-16K |
Net common stock issuance | ---6.04M | -31.55%128K | -15,300.00%-1.85M | -3,984.76%-4.29M | 60.00%-28K | --0 | -87.52%187K | 29.41%-12K | -12.90%-105K | 94.83%-70K |
Net other financing activities | 33.08%-176K | ---- | ---- | ---- | ---- | 83.75%-263K | ---- | ---- | ---- | ---- |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | -1,884.98%-6.21M | 36.84%-48K | -6,272.41%-1.85M | -3,415.57%-4.29M | 67.44%-28K | 81.51%-313K | 52.20%-76K | 29.27%-29K | -6.09%-122K | 93.76%-86K |
Net cash flow | ||||||||||
Beginning cash position | -25.71%29.76M | -12.66%27.44M | -6.79%27.58M | -50.51%31.05M | -25.71%29.76M | -3.19%40.05M | -55.79%31.41M | -46.78%29.59M | 32.71%62.74M | -3.19%40.05M |
Current changes in cash | 77.80%-2.29M | 102.11%35K | -107.77%-142K | 89.53%-3.47M | -94.30%1.29M | -681.26%-10.3M | 94.66%-1.66M | -88.19%1.83M | -498.40%-33.15M | 284.41%22.68M |
End cash Position | -7.68%27.47M | -7.68%27.47M | -12.66%27.44M | -6.79%27.58M | -50.51%31.05M | -25.71%29.76M | -25.71%29.76M | -55.79%31.41M | -46.78%29.59M | 32.71%62.74M |
Free cash flow | 28.43%-3.78M | 147.40%976K | 113.96%707K | -176.62%-1.43M | -21,115.79%-4.03M | -456.65%-5.28M | -352.02%-2.06M | -191.96%-5.06M | 411.35%1.87M | 99.72%-19K |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |